{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:43Z","timestamp":1747224523314,"version":"3.40.5"},"reference-count":11,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>We report the case of a patient with chronic granulomatous disease and acne treated with isotretinoin, who developed a diffuse staphylococcal skin infection during the therapy. Chronic granulomatous disease is a rare genetic disorder characterized by an altered innate immunity with an increased risk of potentially lethal bacterial and fungal infections. Although chronic granulomatous disease is rare, acne is a common manifestation in these patients, but there are no data about the gold standard therapy.<\/jats:p>","DOI":"10.4081\/dr.2023.9631","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T09:59:47Z","timestamp":1672307987000},"source":"Crossref","is-referenced-by-count":1,"title":["A case of chronic granulomatous disease and acne: is isotretinoin a safe treatment?"],"prefix":"10.4081","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-7197","authenticated-orcid":false,"given":"Marco","family":"Brusasco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Feliciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Beatrice","family":"De Felici del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"8489","doi-asserted-by":"crossref","unstructured":"Henrickson SE, Jongco AM, Thomsen KF, et al. Noninfectious Manifestations and Complications of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S18-S24.","DOI":"10.1093\/jpids\/piy014"},{"key":"8490","doi-asserted-by":"crossref","unstructured":"Magnani A, Brosselin P, Beaut\u00e9 J, et al. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol. 2014;134(3):655-662.e8.","DOI":"10.1016\/j.jaci.2014.04.014"},{"key":"8491","doi-asserted-by":"crossref","unstructured":"King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107(5):583-590.","DOI":"10.1111\/j.1365-2133.1982.tb00410.x"},{"key":"8492","doi-asserted-by":"crossref","unstructured":"Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol. 1986;86(4):390-393.","DOI":"10.1111\/1523-1747.ep12285658"},{"key":"8493","doi-asserted-by":"crossref","unstructured":"Leyden JJ, James WD. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol. 1987;123(5):606-608.","DOI":"10.1001\/archderm.123.5.606"},{"key":"8494","doi-asserted-by":"crossref","unstructured":"Alonso-de-Celada RM, de-Lucas Laguna R. Safe and successful treatment of acne vulgaris with isotretinoin in a patient with chronic granulomatous disease. Pediatr Dermatol. 2012;29(5):662-663.","DOI":"10.1111\/j.1525-1470.2011.01510.x"},{"key":"8495","doi-asserted-by":"crossref","unstructured":"Barbi E, Berti I, Minute M, Zennaro F. Successful treatment of acne with isotretinoin in chronic granulomatous disease. Eur J Dermatol. 2011;21(1):111-112.","DOI":"10.1684\/ejd.2010.1171"},{"key":"8496","doi-asserted-by":"crossref","unstructured":"Spillane AP, Hivnor CM. Isotretinoin use in a case of chronic granulomatous disease. Pediatr Dermatol. 2009;26(6):756-758.","DOI":"10.1111\/j.1525-1470.2009.01031.x"},{"key":"8497","doi-asserted-by":"crossref","unstructured":"Kemp A, Rogers M, Kamath R. Retinoid-associated hypertriglyceridemia in chronic granulomatous disease. Am J Med. 1989;86(3):360-361.","DOI":"10.1016\/0002-9343(89)90319-7"},{"key":"8498","doi-asserted-by":"crossref","unstructured":"von Bernuth H, Wahn V. Systemic treatment with isotretinoin suppresses itraconazole blood level in chronic granulomatous disease. Pediatr Allergy Immunol. 2014;25(4):405-407.","DOI":"10.1111\/pai.12181"},{"key":"8499","doi-asserted-by":"crossref","unstructured":"Stevison F, Kosaka M, Kenny JR, et al. Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug-Drug Interactions? Preclinical and Clinical Studies With 13-cis-Retinoic Acid. Clin Transl Sci. 2019;12(4):350-360","DOI":"10.1111\/cts.12616"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9631\/9013","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9631\/9013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T09:59:53Z","timestamp":1672307993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/view\/9631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":11,"URL":"https:\/\/doi.org\/10.4081\/dr.2023.9631","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"type":"electronic","value":"2036-7406"},{"type":"print","value":"2036-7392"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}